MEGAN DUFFY: Open Payments
NPI 1952975799 · SAN PEDRO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,141 in 55 payments from 13 companies in 2025. Trend: 2023 $311 · 2024 $1,203 · 2025 $1,141
Food & beverage: $1,141
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $254 |
| Novo Nordisk Inc | 10 | $222 |
| Amgen Inc. | 11 | $145 |
| PFIZER INC. | 5 | $115 |
| Exact Sciences Corporation | 1 | $99 |
| Regeneron Healthcare Solutions, Inc. | 2 | $72 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $51 |
| GlaxoSmithKline, LLC. | 2 | $44 |
| SHIELD THERAPEUTICS INC | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
Products named: OTEZLA, The Cologuard Plus Collection Kit, QULIPTA, VRAYLAR, ELIQUIS, EVKEEZA, UBRELVY, Ozempic.
Industry payments across CA — which companies pay providers there.
